OTC · CWBHF
Charlotte's Web Holdings, Inc.
$0.24-$0.00 (-0.04%)
Charlotte's Web Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.46% below the high.
Loading market information…
TSXV · VM.V · CAD
Stock price, earnings
Quote as of Oct 29, 2026, 06:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Voyageur Pharmaceuticals Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Voyageur Pharmaceuticals Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived from bromine. It possesses complete ownership of three barium sulfate deposits in British Columbia, Canada, two of which are of a quality appropriate for the pharmaceutical barite sector. Furthermore, Voyageur holds stakes in a valuable brine project in Utah, United States, known for its high concentrations of iodine, lithium, and bromine. The company transitioned from its previous name, Voyageur Minerals Ltd., to Voyageur Pharmaceuticals Ltd. in December 2019. Its corporate headquarters are located in Calgary, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.24-$0.00 (-0.04%)
Charlotte's Web Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.46% below the high.
CA$4.65-CA$0.21 (-4.32%)
BriaCell Therapeutics Corp.’s quoted price sits in the lower half of its reported 52-week range, 74.17% below the high.
CA$0.07CA$0.00 (0.0%)
MediPharm Labs Corp.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CA$0.08+CA$0.01 (+6.67%)
Resverlogix Corp.’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
CA$0.38-CA$0.01 (-2.6%)
Rubicon Organics Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.5% below the high.
CA$0.14-CA$0.02 (-12.9%)
Perimeter Medical Imaging AI, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
CA$0.10-CA$0.01 (-4.76%)
Avicanna Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.29% below the high.
CA$0.08CA$0.00 (0.0%)
Greenway Greenhouse Cannabis Corporation’s quoted price sits in the lower half of its reported 52-week range, 63.64% below the high.
